Answers are grounded in this paper and cite their sources.
Case assessments reveal inaccuracies in renal function tests for transplant patients, highlighting the need for improved methods.
The growing interest in chronic kidney failure underlines the importance of precise assessment of renal function (1). This issue has been less studied in the failing graft, in which renal function quantification may be particularly difficult, because of patients’ clinical complexities and because of pharmacologic interferences. Although in Europe, 24-hr urine collection is routinely used, the American Society of Transplantation recommends the use of creatinine-based formulas, optionally integrated with more precise measurements, not specifically defined (2). Recent studies on patients with liver or heart transplantation and renal failure suggest that, under calcineurin inhibitors, creatinine-based indexes are poor indicators of renal function (3–4). The following cases may draw attention on this rather neglected, albeit clinically relevant problem. Case 1 This was a 30-year-old man, receiving renal replacement therapy since 1994 because of chronic glomerulonephritis, who received a living donor graft in 1995. In April 2001, he developed acute thrombotic microangiopathy, with rapid decrease of renal function. Despite high creatinine clearance (assessed: 19 mL/min; Cockroft and Gault: 17.9 mL/min), the patient developed acidosis, restless legs syndrome, and hyperparathyroidism. Urea clearance was 6.5 mL/min and the mathematical mean of urea and creatinine clearance, often used in dialysis patients, indicated a lower functional level (12.75 mL/min) (1). Radioisotopic study (51CR-EDTA plasma clearance, according to Bröchner-Mortensen: 7.8 mL/min/1.73 m2) (5) supported the choice to restart dialysis. Case 2 This was a 37-year-old man, receiving renal replacement therapy since July 1982 for focal segmental glomerulosclerosis, who received a third renal graft in 1997. In September 2002, he presented a rapidly progressive renal function impairment, with severe proteinuria (35 g/24 hr) and oligoanuria (200–400 mL/24 hr). He was started on a four sessions per week dialysis schedule. In October 2002, renal functional assessment revealed the following: creatinine clearance, 21 mL/min; urea clearance, 2.8 mL/min; Cockroft and Gault, formula 19.1 mL/min. The finding of a high radioisotopic glomerular filtration rate (19.3 mL/min/1.73 m2) was at the basis for an aggressive plasmapheretic approach. The patient has resumed renal function (creatinine clearance 45–60 mL/min), with persistently high 24-hr proteinuria (12–18 g/24 hr). The discrepancy between urea and creatinine clearances may be explained differently in these two cases. However, this posthoc evaluation was made possible by the comparison with the radioisotopic clearance, chosen as the gold standard in renal function assessment. In the first case, the creatinine-based formulas overestimated glomerular filtration, in keeping with previous reports (3–4). In the second case, urea clearance underestimated renal function, presumably because of a combination of low urinary output and circulating volume depletion. In both, the correct quantification of renal function was crucial: in the first patient, relying on creatinine clearance could impair a timely start of dialysis; in the second, urea-based calculations would probably support an abstention-based therapeutic approach. These two examples of pathophysiologic mechanisms potentially biasing functional assessment in the failing graft suggest the need to explore, in a larger patient series, the use of radioisotopic clearances in patients with discrepant data on the usual renal functional tests.
No takes yet. Share an insight, caveat, or question.
Barbara et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: